Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Topical Ruxolitinib may safely treat severe hair loss.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

SH-340 may improve skin barrier and help treat atopic dermatitis.

The FDA approved a new Pfizer drug for hair loss in teens.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

The compound 4c showed strong potential as an anticancer agent.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

The method accurately measures the amount of ketoconazole in anti-dandruff shampoo and cream, and can also be used to monitor the drug in human plasma.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.